The Magnificent Seven stocks propelled the Nasdaq-100 Index (NDX) to a gain of 3.46% for the month ending June 12. And that gauge has risen by nearly 14% over the past 90 days.

Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry.

CEG surges 43.2% in 3 months as it taps nuclear power to fuel rising AI data center demand with long-term deals.

Twilio aims to boost profit through cross-selling, with large customers rising 37% in the first quarter.

Great Lakes Dredge & Dock Corporation's GLDD current valuation is enticing for investors. Currently, the stock is trading below its industry peers with a forward 12-month price-to-earnings (P/E) ratio of 12.43X, as evidenced by the chart below.

@ProsperTradingAcademy's Scott Bauer says Meta Platforms (META) is a stock to "buy the dip" on any pullback, saying it continues to build its position in A.I. META announced a $14.3B investment into Scale AI as Mark Zuckerberg aims to create a superintelligence lab.

Boeing (NYSE:BA) declined by 5% on Thursday, June 12, following the devastating crash of an Air India 787 Dreamliner, resulting in the death of 241 individuals. Although the 787 is generally regarded as a very safe aircraft, Boeing has encountered considerable scrutiny and penalties over the past year due to ongoing quality control problems, especially regarding its 737 MAX fleet.

Key Takeaways

Adobe (NASDAQ:ADBE) recently revealed its Q2 results (fiscal year ending in November), exceeding analyst expectations. The firm reported earnings of $5.06 per share on revenues of $5.9 billion, surpassing the consensus estimates of $4.97 per share and $5.8 billion, respectively.

NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Cable One, Inc. ("Cable One" or the "Company") (NYSE:CABO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ:CAPR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

LEHIGH VALLEY, Pa. , June 13, 2025 /PRNewswire/ -- Air Products (NYSE:APD) will showcase industrial gas solutions and technologies for metals and materials processing applications at the PowderMet2025 International Conference on Powder Metallurgy and Particulate Materials from June 15-18 at the Sheraton Phoenix Downtown in Phoenix, Arizona.

NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ADTRAN Holdings, Inc.("ADTRAN" or the "Company") (NASDAQ:ADTN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company") (NYSE:GMED). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

BOULDER, Colo. , June 13, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that it has priced its previously announced underwritten public offering of 8,394,737 shares of its common stock at a price to the public of $19.66 per share and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase up to 1,780,263 shares of Enliven's common stock at a price to the public of $19.659 per pre-funded warrant, which represents the per share public …

NEW YORK, NY / ACCESS Newswire / June 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Gilead Sciences, Inc. ("Gilead Sciences, Inc.") (NASDAQ:GILD) concerning possible violations of federal securities laws. Gilead issued a press release on June 10, 2025, announcing that "[t]he U.S. Food and Drug Administration has placed a clinical hold on Gilead's HIV treatment trials of GS-1720 (an investigational integrase strand transfer inhibitor) and/or GS-4182 (an investigational capsid inhibitor)[,]" specifying that "[t]he clinical hold is due to the identification of a safety signal of decreases in CD4+T-cell (CD4) and absolute lymphocyte …

NEW YORK CITY, NY / ACCESS Newswire / June 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Metallus Inc. ("Metallus" or the "Company") (NYSE:MTUS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

NEW YORK, NY / ACCESS Newswire / June 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Petco Health and Wellness Company, Inc. ("Petco") (NASDAQ:WOOF) concerning possible violations of federal securities laws. Petco issued a press release on June 5, 2025, reporting its financial results for the first quarter of 2025.

NEW YORK, NY / ACCESS Newswire / June 13, 2025 / If you suffered a loss on your Vestis Corporation (NYSE:VSTS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/vestis-corporation-lawsuit-submission-form?prid=152986&wire=1&utm_campaign=9 or contact Joseph E. Levi, Esq.

Cenovus Energy fully restores production at its key Christina Lake site after wildfire-related shutdowns in Alberta.